APA (7th ed.) Citation

W, S., Y, W., & M, S. (2024). T cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes. ACR open rheumatology, 6(11), 756. https://doi.org/10.1002/acr2.11712

Chicago Style (17th ed.) Citation

W, Stohl, Wu Y, and Stohl M. "T Cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes." ACR Open Rheumatology 6, no. 11 (2024): 756. https://doi.org/10.1002/acr2.11712.

MLA (9th ed.) Citation

W, Stohl, et al. "T Cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes." ACR Open Rheumatology, vol. 6, no. 11, 2024, p. 756, https://doi.org/10.1002/acr2.11712.